0000950170-24-104186.txt : 20240905
0000950170-24-104186.hdr.sgml : 20240905
20240905192607
ACCESSION NUMBER: 0000950170-24-104186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240903
FILED AS OF DATE: 20240905
DATE AS OF CHANGE: 20240905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILNE GEORGE M JR
CENTRAL INDEX KEY: 0001179552
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41199
FILM NUMBER: 241282633
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464600503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-683-0917
MAIL ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
ownership.xml
4
X0508
4
2024-09-03
0001658551
Amylyx Pharmaceuticals, Inc.
AMLX
0001179552
MILNE GEORGE M JR
C/O AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET
CAMBRIDGE
MA
02141
true
false
false
false
false
Common Stock
2024-09-03
4
P
false
100000
2.1980
A
858571
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.14 to $2.235. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
/s/ Joshua B. Cohen, as Attorney in Fact
2024-09-05